No Data
No Data
Declining Stock and Solid Fundamentals: Is The Market Wrong About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)?
It is hard to get excited after looking at Tianjin Pharmaceutical Da Ren Tang Group's (SHSE:600329) recent performance, when its stock has declined 16% over the past month. However, a closer look at
Tj Darentang (600329.SH) plans to distribute a dividend of RMB 1.28 per share in 2023, with the ex-rights and ex-dividends date being July 12.
tj darentang usd (600329.SH) announced that it plans to distribute a cash dividend of 1.28 yuan per share (including tax) for the year 2023. The record date is July 11th, 2024, and the ex-dividend date is July 12th, 2024.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) Last Week's 5.9% Decline Must Have Disappointed Individual Investors Who Have a Significant Stake
Key Insights Tianjin Pharmaceutical Da Ren Tang Group's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 12
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Shareholders Have Earned a 22% CAGR Over the Last Five Years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on a lighter note, a good company can see its share price rise well over
Investors Still Aren't Entirely Convinced By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) Earnings Despite 25% Price Jump
Despite an already strong run, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) shares have been powering on, with a gain of 25% in the last thirty days. Unfortunately, th
Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3%
Tianjin Pharmaceutical Da Ren Tang's (SHA:600329) attributable profit fell 3.4% year over year to 387.3 million yuan in the first quarter, according to a Tuesday filing with the Shanghai Stock Exchang
No Data